Wei Jiang
Wei Jiang
Verified email at
Cited by
Cited by
The other function: class II-restricted antigen presentation by B cells
LN Adler, W Jiang, K Bhamidipati, M Millican, C Macaubas, S Hung, ...
Frontiers in immunology 8, 319, 2017
HLA-DO acts as a substrate mimic to inhibit HLA-DM by a competitive mechanism
AI Guce, SE Mortimer, T Yoon, CA Painter, W Jiang, ED Mellins, LJ Stern
Nature structural & molecular biology 20 (1), 90-98, 2013
CD4+ T Cell Autoimmunity to Hypocretin/Orexin and Cross-Reactivity to a 2009 H1N1 Influenza A Epitope in Narcolepsy
AK De la Herran-Arita, BR Kornum, J Mahlios, W Jiang, L Lin, T Hou, ...
Science translational medicine 5 (216), 216ra176-216ra176, 2013
Assembly and architecture of the EBV B cell entry triggering complex
K Sathiyamoorthy, J Jiang, YX Hu, CL Rowe, BS Möhl, J Chen, W Jiang, ...
PLoS Pathogens 10 (8), e1004309, 2014
Susceptibility to HLA-DM protein is determined by a dynamic conformation of major histocompatibility complex class II molecule bound with peptide
L Yin, P Trenh, A Guce, M Wieczorek, S Lange, J Sticht, W Jiang, ...
Journal of Biological Chemistry 289 (34), 23449-23464, 2014
On the perils of poor editing: regulation of peptide loading by HLA-DQ and H2-A molecules associated with celiac disease and type 1 diabetes
R Busch, A De Riva, AV Hadjinicolaou, W Jiang, T Hou, ED Mellins
Expert reviews in molecular medicine 14, e15, 2012
High-throughput engineering and analysis of peptide binding to class II MHC
W Jiang, ET Boder
Proceedings of the National Academy of Sciences 107 (30), 13258-13263, 2010
Engineering antibodies for cancer therapy
ET Boder, W Jiang
Annual review of chemical and biomolecular engineering 2, 53-75, 2011
In vivo clonal expansion and phenotypes of hypocretin-specific CD4+ T cells in narcolepsy patients and controls
W Jiang, JR Birtley, SC Hung, W Wang, SH Chiou, C Macaubas, ...
Nature communications 10 (1), 5247, 2019
Mapping the HLA-DO/HLA-DM complex by FRET and mutagenesis
T Yoon, H Macmillan, SE Mortimer, W Jiang, CH Rinderknecht, LJ Stern, ...
Proceedings of the National Academy of Sciences 109 (28), 11276-11281, 2012
New insights into B cells as antigen presenting cells
D Ghosh, W Jiang, D Mukhopadhyay, ED Mellins
Current Opinion in Immunology 70, 129-137, 2021
Retraction of the Research Article: "CD4+ T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 influenza A epitope in narcolepsy"
AK De la Herrán-Arita, BR Kornum, J Mahlios, W Jiang, L Lin, T Hou, ...
Science translational medicine 6 (247), 247rt1-247rt1, 2014
pH-susceptibility of HLA-DO tunes DO/DM ratios to regulate HLA-DM catalytic activity
W Jiang, MJ Strohman, S Somasundaram, S Ayyangar, T Hou, N Wang, ...
Scientific reports 5 (1), 17333, 2015
Human intestinal enteroids model MHC-II in the gut epithelium
JE Wosen, A Ilstad-Minnihan, JY Co, W Jiang, D Mukhopadhyay, ...
Frontiers in Immunology 10, 1970, 2019
The MHC class II cofactor HLA-DM interacts with Ig in B cells
H Macmillan, MJ Strohman, S Ayyangar, W Jiang, N Rajasekaran, ...
The Journal of Immunology 193 (6), 2641-2650, 2014
Yeast display of MHC-II enables rapid identification of peptide ligands from protein antigens (RIPPA)
R Liu, W Jiang, ED Mellins
Cellular & Molecular Immunology 18 (8), 1847-1860, 2021
Synergy between B cell receptor/antigen uptake and MHCII peptide editing relies on HLA-DO tuning
W Jiang, LN Adler, H Macmillan, ED Mellins
Scientific reports 9 (1), 13877, 2019
Epitope selection for HLA-DQ2 presentation: implications for celiac disease and viral defense
SC Hung, T Hou, W Jiang, N Wang, SW Qiao, I Chow, X Liu, ...
The Journal of Immunology 202 (9), 2558-2569, 2019
TCR-like antibodies targeting autoantigen-mhc complexes: A mini-review
Y Li, W Jiang, ED Mellins
Frontiers in Immunology 13, 968432, 2022
Tuning DO: DM ratios modulates MHC class II immunopeptidomes
N Olsson, W Jiang, LN Adler, ED Mellins, JE Elias
Molecular & Cellular Proteomics 21 (3), 2022
The system can't perform the operation now. Try again later.
Articles 1–20